Foo-Lab

Roger trained with the late Professor David de Bono (British Heart Foundation Chair of Cardiology, Leicester, UK).

(Read about inspirational Physician Davide De Bono here)

Roger subsequently moved to the Department of Clinical Pharmacology, Cambridge, UK, working under the tutelage of

Professor Morris Brown MD, FRCP, FMedSci

After being awarded a Wellcome Trust Fellowship Roger then moved to Albert Einstein College of Medicine, NYC with Professor Rick Kitsis where he delved into the molecular regulation of heart failure and cardiomyocyte apoptosis.

(Richard N. Kitsis, M.D.)

Upon returning to Cambridge, Roger started the Foo-Lab 1.0 at the Division of Cardiovascular Medicine, funded by the British Heart Foundation and Wellcome Trust, exploring the mechanisms that regulate gene expression and cardiac epigenomics in Heart Failure.

The Foo-Lab 2.0 was established in Singapore in 2013 at both NUS CVRI and the Genome Institute of Singapore. Since returning to his roots in Singapore, the lab has widened its exploration further into new molecular mechanisms of Heart Failure, adopting new technologies to explore gene expression control, cell states transitions and cardiac function.

Using clinical samples, in vitro reprogrammed stem cells, and a variety of in vivo models, Foo Lab applies cutting edge advances in science to better understand cardiac biology and disease. Recently Roger has taken on several leadership roles at NUS and the lab has expanded into clinical and population health, driving “closer to the patient” in full concerted effort towards heart disease prevention and tackling the looming heart failure crisis in Southeast Asia.